Systemic chemotherapy with capecitabine, doxorubicin and cisplatin for metastatic hepatocellular carcinoma.

被引：0
|
作者：
Shin, D
Lee, SI
Park, J
Park, SH
Bang, SM
Cho, EK
Lee, JH
机构：
[1] Gachon Med Sch, Gil Med Ctr, Inchon, South Korea
[2] Dankook Univ Hosp, Cheonan, South Korea
[3] Cheju Natl Univ Hosp, Cheju, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：352S / 352S
页数：1
相关论文
共 50 条
  • [1] Systemic chemotherapy with doxorubicin, cisplatin and capecitabine for metastatic hepatocellular carcinoma
    Park, SH
    Lee, Y
    Han, SH
    Kwon, SY
    Kwon, OS
    Kim, SS
    Kim, JH
    Park, YH
    Lee, JN
    Bang, SM
    Cho, EK
    Shin, BD
    Lee, JH
    [J]. BMC CANCER, 2006, 6 (1)
  • [2] Systemic chemotherapy with doxorubicin, cisplatin and capecitabine for metastatic hepatocellular carcinoma
    Se Hoon Park
    Yuna Lee
    Sang Hoon Han
    So Young Kwon
    Oh Sang Kwon
    Sun Suk Kim
    Ju Hyun Kim
    Yeon Ho Park
    Jeong Nam Lee
    Soo-Mee Bang
    Eun Kyung Cho
    Dong Bok Shin
    Jae Hoon Lee
    [J]. BMC Cancer, 6
  • [3] Combination chemotherapy with capecitabine and cisplatin for patients with metastatic hepatocellular carcinoma
    Lee, J. O.
    Lee, K. W.
    Oh, D. Y.
    Kim, J. H.
    Im, S. A.
    Kim, T. Y.
    Bang, Y. J.
    [J]. ANNALS OF ONCOLOGY, 2009, 20 (08) : 1402 - 1407
  • [4] Cisplatin and capecitabine induction chemotherapy in nasopharyngeal carcinoma.
    Xu, Zhiyuan
    Yang, Li
    Lee, Victor Ho-Fun
    Lee, Anne W. M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [5] Phase II study of doxorubicin and cisplatin in patients with metastatic hepatocellular carcinoma
    Lee, J
    Park, JO
    Kim, WS
    Park, SH
    Park, KW
    Choi, MS
    Lee, JH
    Koh, KC
    Paik, SW
    Yoo, BC
    Joh, J
    Kim, K
    Jung, CW
    Park, YS
    Im, YH
    Kang, WK
    Lee, MH
    Park, K
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2004, 54 (05) : 385 - 390
  • [6] Phase II study of doxorubicin and cisplatin in patients with metastatic hepatocellular carcinoma
    Jeeyun Lee
    Joon Oh Park
    Won Seog Kim
    Se Hoon Park
    Keon Woo Park
    Moon Seok Choi
    Joon Hyoek Lee
    Kwang Cheol Koh
    Seung Woon Paik
    Byung Chul Yoo
    Jaewon Joh
    Kihyun Kim
    Chul Won Jung
    Young Suk Park
    Young-Hyuck Im
    Won Ki Kang
    Mark H. Lee
    Keunchil Park
    [J]. Cancer Chemotherapy and Pharmacology, 2004, 54 : 385 - 390
  • [7] Efficacy of combination chemotherapy with capecitabine plus cisplatin in patients with unresectable hepatocellular carcinoma
    Shim, Ju Hyun
    Park, Joong-Won
    Nam, Byung Ho
    Lee, Woo Jin
    Kim, Chang-Min
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (03) : 459 - 467
  • [8] Efficacy of combination chemotherapy with capecitabine plus cisplatin in patients with unresectable hepatocellular carcinoma
    Ju Hyun Shim
    Joong-Won Park
    Byung Ho Nam
    Woo Jin Lee
    Chang-Min Kim
    [J]. Cancer Chemotherapy and Pharmacology, 2009, 63 : 459 - 467
  • [9] ARSENIC TRIOXIDE PLUS CISPLATIN/INTERFERON ALPHA-2B/DOXORUBICIN/CAPECITABINE IN VITRO COMBINATION CHEMOTHERAPY FOR HEPATOCELLULAR CARCINOMA
    Tomuleasa, Ciprian
    Soritau, Olga
    Fischer-Fodor, Eva
    Pop, Teodora
    Mosteanu, Ofelia
    Pintea, Bogdan
    Kacso, Gabriel
    Irimie, Alexandru
    Acalovschi, Monica
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (09): : 1095 - 1095
  • [10] Role of metronomic capecitabine in advanced hepatocellular carcinoma.
    Mateen, Abdul
    Adil, Allah Rakha
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345